1. Home
  2. CLLS vs GCTS Comparison

CLLS vs GCTS Comparison

Compare CLLS & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • GCTS
  • Stock Information
  • Founded
  • CLLS 1999
  • GCTS 1998
  • Country
  • CLLS France
  • GCTS United States
  • Employees
  • CLLS N/A
  • GCTS N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • GCTS Blank Checks
  • Sector
  • CLLS Health Care
  • GCTS Finance
  • Exchange
  • CLLS Nasdaq
  • GCTS Nasdaq
  • Market Cap
  • CLLS 240.2M
  • GCTS 113.6M
  • IPO Year
  • CLLS 2007
  • GCTS N/A
  • Fundamental
  • Price
  • CLLS $1.57
  • GCTS $2.28
  • Analyst Decision
  • CLLS Buy
  • GCTS Strong Buy
  • Analyst Count
  • CLLS 3
  • GCTS 1
  • Target Price
  • CLLS $7.00
  • GCTS $8.00
  • AVG Volume (30 Days)
  • CLLS 59.8K
  • GCTS 178.2K
  • Earning Date
  • CLLS 11-04-2024
  • GCTS 11-14-2024
  • Dividend Yield
  • CLLS N/A
  • GCTS N/A
  • EPS Growth
  • CLLS N/A
  • GCTS N/A
  • EPS
  • CLLS N/A
  • GCTS N/A
  • Revenue
  • CLLS $36,042,000.00
  • GCTS $11,532,000.00
  • Revenue This Year
  • CLLS $271.02
  • GCTS N/A
  • Revenue Next Year
  • CLLS $33.48
  • GCTS $459.37
  • P/E Ratio
  • CLLS N/A
  • GCTS N/A
  • Revenue Growth
  • CLLS 46.96
  • GCTS N/A
  • 52 Week Low
  • CLLS $1.53
  • GCTS $2.12
  • 52 Week High
  • CLLS $3.55
  • GCTS $56.00
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 27.91
  • GCTS 42.13
  • Support Level
  • CLLS $1.85
  • GCTS $2.45
  • Resistance Level
  • CLLS $2.09
  • GCTS $2.70
  • Average True Range (ATR)
  • CLLS 0.09
  • GCTS 0.21
  • MACD
  • CLLS -0.04
  • GCTS -0.02
  • Stochastic Oscillator
  • CLLS 0.00
  • GCTS 15.85

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.

About GCTS GCT Semiconductor Holding Inc. Common Stock

GCT Semiconductor Holding Inc. is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.

Share on Social Networks: